Personalised peptide vaccination promising in bladder cancer

November 27, 2015

Metastatic bladder cancer patients who have progressed on first-line platinum-based chemotherapy could derive survival benefits from personalised peptide vaccination, according to phase II trial results.

Previous Article
Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed
Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

A large population-based study has confirmed the association between the presence of human papillomavirus D...

Next Article
Prehospital combination therapy disappoints in status epilepticus
Prehospital combination therapy disappoints in status epilepticus

Adding levetiracetam to prehospital treatment with clonazepam does not improve control of generalised convu...